Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

Tous les articles

Press Coverage

Press Coverage

ISMP Issues Alert on Remdesivir Labeling, Propofol Dosing

This article appeared on the Infectious Disease Special Edition website on May 20, 2020.

Press Coverage

Press Coverage

Push Is on to Make IV Workflow Systems Universal

This article appeared on the Pharmacy Practice News website on May 19, 2020.

Press Coverage

Press Coverage

FDA Aims to Thwart Infusion Pump Shortage with Industrywide Emergency Use Authorization

This article appeared on the MedTech Dive website on May 15, 2020.

Press Coverage

Press Coverage

This article appeared on the Becker’s Hospital Review website on May 15, 2020.

Press Coverage

Press Coverage

Preventing Medication Errors at Small and Rural Hospitals

This article appeared on the Pharmacy Practice News website on May 6, 2020.

Press Coverage

Press Coverage

Next COVID-19 Device Shortage? “Smart” Infusion Pumps

This article appeared on the Medical Design and Outsourcing website on April 27, 2020.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all